Illumina Inc (ILMN.O) on Thursday agreed to terminate the $1.2 billion deal to buy smaller rival Pacific Biosciences of California Inc (PACB.O), weeks after the U.S. competition watchdog filed a complaint to block the...
FTC files complaint to block Illumina from buying PacBio
The Federal Trade Commission has filed a complaint aimed at stopping Illumina Inc from purchasing Pacific Biosciences of California, the agency said on Tuesday. Shares of PacBio fell about 7.5 percent in after-hours...
Reliance’s biotech arm eyes tie-ups to enter diagnostics business
Mukesh Ambani, India’s richest man, now wants a share of your diagnostics budget, in a move that can potentially shake up the sector similar to the disruption in the telecom market after the entry of Reliance Jio...
NCLAT gives 30 days more to Sterling Biotech promoters to settle dues
The National Company Law Appellate Tribunal has granted 30 days more to the promoters of Sterling Biotech to settle dues of creditors, failing which liquidation process of the company will start. A three-member bench...
Advent set to buy controlling stake in Bharat Serum
Private equity group Advent International is buying a controlling stake in Mumbai-based biopharma company Bharat Serums and Vaccines (BSV), valuing the company for $500 million (Rs 3500 cr). A formal announcement is...
Amgen takes 20.5% stake in BeiGene to sell cancer drugs in China
Amgen Inc said on Thursday it will take a 20.5% stake in BeiGene Ltd in a deal to expand the California-based biotechnology company’s presence in China, the world’s second largest pharmaceutical market. Amgen said it...
SoftBank-backed Vir Biotechnology raises $143 million in U.S. IPO
Vir Biotechnology VIR.O priced its initial public offering (IPO) at $20 a share on Thursday, at the bottom end of expectations, the latest underwhelming investment performance for a stock held by SoftBank Group...
Biocon subsidiary acquires research facility from Pfizer Healthcare
Biotechnology major Biocon on Tuesday said its subsidiary has acquired a Chennai-based biological research facility from Pfizer Healthcare for an undisclosed amount. Biocon Biologics has acquired research and...
Sterling Biotech case: Appellate authority upholds IBC over PMLA
In a ruling upholding the prevalence of the Insolvency and Bankruptcy Code (IBC) over the Prevention of Money Laundering Act (PMLA), the appellate authority of the PMLA has released some properties, belonging to PMT...
NCLAT stays eviction of Sterling Biotech from its premise
The National Company Law Appellate Tribunal (NCLAT) has stayed eviction of Sterling Biotech from its premises as the debt-ridden company was going under the insolvency resolution process and was under the moratorium...
Woodford biotech stakes first off block in asset sale – source
British fund manager Neil Woodford is looking to kick off the sale of his unlisted biotech investments at the end of July, but faces months of negotiations to offload the portfolio, a source familiar with the matter...
Gilead invests $5 billion to deepen ties with biotech Galapagos
U.S. antiviral drugmaker Gilead Sciences (GILD.O) will invest $5.1 billion in a major expansion of its partnership with Belgo-Dutch biotech Galapagos NV (GLPG.AS), news that lifted Galapagos’s shares more than 18% to an...
